{"nct_id":"NCT00576173","title":"An Open Label Study to Evaluate Safety, Tolerability and Clinical Utility of ULTRACET® (37.5mg Tramadol Hydrochloride/325mg Acetaminophen) for the Treatment of Breakthrough Pain in Cancer Patients","status":"COMPLETED","status_verified_date":"2010-04","start_date":"2005-12","start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":"2007-02","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["JNJ"]}